CD200 and acute myeloid leukemia: As demonstrated in AML studies [38], CD200 expression has been associated with reduced levels of CD4+ and CD8+ memory T cells along with a concomitant decrease in the production of pro-inflammatory Th1 cytokines, including TNF-α, IL-2, and IFN-γ.